We recently welcomed Dr. Stephen Ruby, MD, MBA, FCAP, to discuss the importance of having a buy-sell agreement in place for your lab or practice and how your accounts receivable factors in to that discussion.
In his latest video, Vachette President Mick Raich reviews a handful of high profile instances of fraud and abuse within the laboratory industry
In his latest video, Vachette President Mick Raich looks ahead to what could lead to an end of the current environment of widespread payer coverage for Covid-19 testing and treatment.
What are the greatest challenges pathologists have experienced in the revenue cycle management world this past year-plus since the Covid-19 Public Health Emergency began?
In this week's update, Vachette and Stark Medical Auditing CEO Mick Raich reviews UHC’s new Designated Diagnostic Provider Program that will restrict outpatient lab payments for labs who don’t gain entry. He also examines a number of recent audit findings and provides an update of the latest Covid billing issues.
Happy New Year! In his first update of 2021, Vachette and Stark Medical Auditing CEO Mick Raich unpacks the details of the latest COVID relief package passed by Congress, including a payment bump for the Medicare Physician Fee Schedule.
Vachette and Stark CEO Mick Raich dons his Santa gear to unpack the lump of coal that is the finalized 2021 Medicare Physician Fee Schedule
This week, Vachette CEO Mick Raich reviews a number of topics we covered in our most recent webinar, including when it is appropriate to bill the Uninsured Patient Portal when performing Covid-19 testing, how these rules pertain to instances of workplace screening, and more.
In his latest update, Vachette and Stark Medical Auditing CEO Mick Raich reviews Medicare’s recent move to lower COVID-19 test payments for labs that don’t produce results within 48 hours and the impact that may have on labs moving forward.
This week, Vachette CEO Mick Raich reviews the hospital price transparency rules that will take effect Jan. 1 and outlines why they may not be a big deal for larger health systems.
In this week's video, Vachette CEO Mick Raich turns his attention to how the upcoming Presidential election between Joe Biden and Donald Trump.
Vachette and Stark Medical Auditing CEO Mick Raich reviews a Medicare policy change for ABNs and looks forward to how the ongoing COVID-19 Public Health Emergency will continue to impact health care providers in concert with the upcoming flu season.
Vachette CEO Mick Raich addresses a number of questions our team has recently received in this Q&A.
In his latest update, Vachette and Stark CEO Mick Raich explores a number of new policy changes from UHC that are continuing to hurt labs during a vulnerable time.
This week, Vachette and Stark Medical Auditing CEO Mick Raich discusses a number of COVID-19 related issues, including what the extension of the Public Health Emergency means for ordering tests.
This week, Vachette CEO Mick Raich discusses the continued push for hospital price transparency, outlines the penalties you could face if your COVID-19 testing cash price isn’t listed publicly on your website and examines a few other COVID-related reimbursement issues.
With Covid-19 showing no sign of slowing down in the near future, many health care providers need to prepare for a potential resurgence this fall that could lead to another pause on elective surgeries or a more comprehensive nationwide shutdown.
In his latest video, Vachette CEO Mick Raich shares his thoughts on what potential liability labs may face if they fail to report this data:
While the discussion surrounding a nationwide solution for surprise billing was a hot topic until earlier this year, there are now many legitimate questions to be asking about how COVID-19 may drive the push for new legislation.
Everyone knows health care providers have been hit hard by COVID-19, but how have insurers been affected? Vachette CEO Mick Raich has the latest.
Billing items that aren't billable, collecting dollars that don't belong to them -- every day we see different examples of unintentional fraud that could be prevented through routine audits and proactive revenue cycle management.
Recently, we encountered a biller who had a policy in place stating they won't appeal denials below $500. While such policies are unfortunately becoming more common, it's still unacceptable for your bottom line.
Curious about how your biller stacks up against the competition? We're happy to fill you in!
Miss our white paper on how to utilize FOIA requests to bolster your position in Medicare Part A contract negotiations with your hospital? Here's a brief rundown on what data you should be requesting from your Medicare Administrative Contractor.
The practice of writing off small balances is common across the medical billing industry, but the threshold for doing so varies wildly from practice to practice. The question you need to be asking is whether you're losing money because of your write-off policy.
Vachette CEO Mick Raich describes the difficulties he faced during the recent Traverse City Iron Man competition, and how overcoming them helps him persevere not only in his personal life, but also in a professional capacity.
Imagine discovering a private payer cut your reimbursement rates by 70 percent! Wouldn’t it be nice to have a team of experts on your side to help navigate such a thorny issue?
Mick Raich, president of Vachette Pathology and Stark Medical Auditing and Consulting, has traveled throughout the country this year to various health care tradeshows and conferences to share his insight on how the health care industry's ongoing transition to value-based medicine will impact your revenue stream, and more importantly, what you can do to prepare.
Vachette President Mick Raich shares his thoughts on the recent news that the Obama administration plans to begin rating health care networks based on the number of physicians and hospitals within a network and also discusses the new Merit-Based Incentive Payment System that will be used to grade physicians starting next year.
As a pathology practice management and auditing firm, Vachette sees it all. Hear Vachette President Mick Raich talk about some of the "scroogy" things going on lately with medical billing and government regulations.
Vachette President Mick Raich talks consolidation in healthcare and what this could mean to your pathology practice revenue.
Have you heard of Extended DRG, or Diagnostic Related Group? If not, you will. Watch as Vachette President Mick Raich explains what this means to you and your pathology practice.
Recently Medicare released a proposed fee schedule — an 815 page document. Vachette President Mick Raich read the whole document ... watch as he boils it down and relates some interesting items that pathology practices will want to take note of.
During CAP ‘10, the College of American Pathologists (CAP) hosted the CAP ‘10 Transformation Plenary. Their objective was to examine the economic reality, technological development and the emerging healthcare models that are redefining the physician’s role around...
Attendees are calling the 2010 ASCP Annual Meeting in San Francisco one of the best. See why by watching the five videos chronicling the news of each day and documenting perspectives on the future of the profession. Videos include interviews with ASCP leaders,...
Who's reviewing revenue strategy with you at this time?
Are you billing all the correct CPT codes? You’d be surprised at what you might be missing. We will review your Fee Schedule/Charge Master at no cost.
That’s right. For free.